title: Physical activity increases bone mineral density in children with type 1 diabetes.
abstract: BACKGROUND
  Osteoporosis is a growing health problem in patients with type 1 diabetes mellitus (T1DM). The aim of this study was to determine the effects of a 9-month weight-bearing physical activity program on bone mineral density (BMD) and bone biomarkers in T1DM compared with healthy children.
  
  
  METHODS
  This was a randomized controlled trial including 27 diabetic and 32 healthy children (mean age = 10.5 ± 2.5 yr). Both T1DM and healthy participants were randomized to either an exercise or a control group (i.e., four groups). At baseline and 9 months, total body (TB), lumbar spine (LS2-LS4), femoral neck, and greater trochanter areal BMD (aBMD) and serum bone biomarkers (osteocalcin, type 1 collagen cross-linking) were measured. The intervention consisted of two 90-min sessions per week of weight-bearing physical activity (ball games, jumping, rope skipping, and gymnastics).
  
  
  RESULTS
  Baseline variables were similar among groups. At 9 months, changes in TB (T1DM = 0.035 ± 0.022 g·cm(-2), healthy = 0.031 ± 0.017 g·cm(-2)) and LS2-LS4 (T1DM = 0.046 ± 0.038 g·cm(-2), healthy = 0.063 ± 0.034 g·cm(-2)) aBMD were statistically significant in the intervention groups and of similar magnitude between T1DM and healthy subjects. The level of type 1 collagen cross-linking (T1DM = -0.12 ± 0.32 ng·mL(-1), healthy = -0.36 ± 0.11 ng·mL(-1)) decreased in the intervention groups but was not associated with TB aBMD changes.
  
  
  CONCLUSIONS
  Regular weight-bearing physical activity (180 min·wk(-1), including ball games, jumping activities, and gymnastics) improves total and LS2-LS4 bone mineral accretion in children with T1DM, in a similar magnitude to healthy subjects. We conclude that children with T1DM should be encouraged to practice regular physical activity to enhance peak bone mass and prevent osteoporosis later in life.
authors.affiliation: Pediatric Sports Medicine and Obesity Care Program, Service of Pediatric Specialties, Department of Child and Adolescent, University Hospital of Geneva, Geneva, Switzerland.
authors.forename: Albane B R
authors.initials: AB
authors.lastname: Maggio
authors.forename: René R
authors.initials: RR
authors.lastname: Rizzoli
authors.forename: Laetitia M
authors.initials: LM
authors.lastname: Marchand
authors.forename: Serge
authors.initials: S
authors.lastname: Ferrari
authors.forename: Maurice
authors.initials: M
authors.lastname: Beghetti
authors.forename: Nathalie Jacqueline
authors.initials: NJ
authors.lastname: Farpour-Lambert
mesh_terms: D015415:Biomarkers / Q000097:blood; D015519:Bone Density; D016022:Case-Control Studies; D002648:Child; D024042:Collagen Type I / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008297:Male; D015675:Osteocalcin / Q000097:blood; D010024:Osteoporosis / Q000517:prevention & control; D055070:Resistance Training / Q000379:methods*; D013557:Switzerland
chemical_list: D015415:Biomarkers; D024042:Collagen Type I; D015675:Osteocalcin